Express Pharma

Product D-Value studies: A critical tool when developing a sterilisation process


Kurt McCauley, R&D Lab Manager, Mesa Laboratories, elaborates on D-Value study on sterilisation

The objective of a sterilisation process is to kill the naturally occurring microbial contamination (bioburden) present in the product. Two common sterilisation methods used are the Bioburden Based Sterilization (BBS) method and the Overkill Sterilization (OS) method. The BBS method is defined as a sterilisation process with parameters based upon the predetermined type and concentration of bioburden on the material being sterilised. The OS method is defined as a sterilisation process that is based upon an arbitrarily established higher initial concentration and resistance of bioburden than that actually expected on the material being sterilised.

What is the bioburden of the product?

The micro-organisms present in product can be viral, bacterial, and fungal and come from three main sources: the manufacturing environment, personnel, and raw materials including water. Some organisms are spore formers, which generally are the most resistant to environmental stresses including sterilisation processes.

The product may have little or no bioburden depending on the manufacturing conditions and raw materials, or it may contain high concentrations of multiple organisms. It is essential to learn as much as possible about the bioburden organisms, especially when running minimal sterilisation cycles (due to product sensitivity to the sterilisation process).

Information required when characterising the bioburden include:

  • Total numbers of organisms present just prior to sterilisation
  • Identity of organisms present
  • Number of spore formers present
  • Resistance of the bioburden
  • Sampling frequency and statistical analysis

What effect does the product have on the bioburden prior to sterilisation?

It is important to know how the product will influence the behaviour of the organisms present. This is particularly important in liquid products. If the product is capable of promoting growth, then over time, a few organisms could eventually result in high numbers of organisms. This presents a problem if there is a significant time delay between manufacture and sterilisation. High numbers of organisms could result in an increase in sterilisation time. Alternately, the material may be bacteriostatic, bactericidal, sporostatic, or sporicidal.

Properties of the material being sterilised (e.g. chemistry of a pharmaceutical product or the physical characteristics of a medical device) can have a significant influence on the resistance of the microorganisms. The product may protect the organisms in numerous ways such as by coating them or causing them to clump, increasing their resistance to the sterilisation process. Alternately, it may make them more susceptible to the sterilisation process.

Figure 1 displays single free floating spores, while Figure 2 displays several large clumps, some of them containing hundreds of spores.

Figure 1. Unclumped spores in ethanol

Figure 2. Clumped spores in product

Why is it acceptable to base sterilisation cycles on the resistance of Geobacillus stearothermophilus spores?

Geobacillus stearothermophilus (ATCC #7953) spores (which typically have D121-values in the 1.5-2.5 minute range on a paper strip) are more resistant than most wild type organisms. These spores, widely used for monitoring steam sterilisation processes, may be substituted for the bioburden organism during resistance testing. When this substitution occurs, it is assumed that the G. stearothermophilus spores are more resistant than the bioburden organisms or by design significantly out number the bioburden organisms. The kill time for the G. stearothermophilus would then exceed the kill time for the bioburden organisms. The Figure 3 chart illustrates this point.

Exposure Time in Minutes

Is it acceptable to base sterilization cycles on the resistance of other organisms?

Other organisms such as Bacillus coagulans (ATCC #7050), B. smithii (formerly B.coagulans ATCC #51232), B. subtilis “5230” (ATCC #35021) and Clostridium sporogenes (ATCC #11437) may be used in certain situations. These organisms are more sensitive to moist heat sterilisation than G. stearothermophilus, but in general, they are still more resistant than the bioburden. It may be desirable to use one of these organisms when the product is sensitive to the sterilisation process, thereby limiting the sterilisation time. However, when working with a heat sensitive product, it is strongly recommended that the bioburden be characterised prior to basing sterilisation parameters on the above mentioned indicator organisms.

Why perform a D-value study?

The most direct method for evaluating the resistance of the test organism (a bioburden isolate or G. stearothermophilus spores) is by performing a D-value study. When evaluating the bioburden, it is not necessary to test every organism isolated, only the most resistant (which can be isolated though the use of a heat shock screening procedure).

How are D-value studies performed?

20170131ep41Ideally, the D-value study should be performed on the actual product spiked with the test organism. Biological Indicator Evaluator Resistometers (B.I.E.R.) vessels 1,2, sterilisers capable of running square wave cycles, are commonly used in D-value studies. D-values can be calculated by using one of two methods, survivor curve or fraction negative analysis. A survivor curve plots the surviving microorganisms against a critical process parameter, usually time. The curve provides an important graphic representation of the kinetics of the microbicidal process 3. Fraction negative analysis, sometimes referred to as “end-point experiments”, focuses on the quantal zone (the area where exposures to replicate units result in both positive and negative units when cultured for growth) 4.

In general, a survivor curve establishes the resistance for surviving populations greater than 5 x 101 whereas the fraction negative method establishes the resistance for surviving populations below 5 x 100.

There are two advantages to the survivor curve method. One is that it can demonstrate a log linear regression curve when doing product testing, which can be extrapolated to demonstrate the calculated SAL. The other is that the product can be removed through filtration so as to eliminate any potential product inhibition on the injured spores.

SGM has years of experience performing these studies on a wide variety of pharma products for R&D and commercial manufacturers.

To have a study performed, the manufacturer will need to supply approximately 100 ml of product and a slant containing the bioburden isolate. SGM can supply spores (traceable to American Type Culture Collection) if a bioburden study is not desired. A typical study consists of 1) inoculating the product with the test organism, 2) filling and sealing the spiked product into very small glass ampoules, 3) performing graded exposures on the ampoules in a B.I.E.R. vessel, and 4) assaying the ampoules for surviving spores. The data collected from these exposures is used to calculate a D-value.

These D-values can be used to calculate an appropriate SAL for the sterilisation process. SGM can also provide a convenient BI challenge, which complements these studies for routine monitoring of the sterilisation process.

1. AAMI Guideline for the use of ethylene oxide and steam biological indicators in industrial sterilization processes. ST34
2. ISO/CD 18472, Sterilization of health care products – Biological and chemical indicators – Test equipment and methods. Draft.
3. ISO 11138-1:1994(E) Annex B.
4. ISO 11138-1:1994 (E) Annex C.

Comments are closed.